Human Models of Selective Insulin Resistance: Alpelisib, Part I

Clinical trial NCT06354088 · RECRUITING

Trial details

NCT number: NCT06354088
Sponsor: Columbia University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Insulin Resistance Prediabetic State Overweight and Obesity Non-Alcoholic Fatty Liver Disease

Start date: 2024-04-24
Primary completion: 2026-12-31
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.